Summary
Thermo Fisher Scientific Inc. (TMO) filed an 8-K on October 24, 2018, primarily to report its financial results for the fiscal quarter ended September 29, 2018. The company announced its earnings, providing investors with key performance indicators and financial condition updates. While the 8-K itself is a brief filing, it serves as the official channel to incorporate the detailed press release containing the quarterly results, which is attached as an exhibit. Investors should refer to the attached press release (Exhibit 99.1) for the specific financial figures, including revenue, earnings per share, and any forward-looking guidance provided by management. This filing is crucial for understanding TMO's recent performance and its implications for future growth and profitability. It's important to note that the information furnished in this 8-K is typically for informational purposes and not deemed "filed" under certain sections of securities laws, meaning it doesn't carry the same liability as a formally filed document, though the press release itself contains the substance of the financial results.
Key Highlights
- 1Thermo Fisher Scientific (TMO) announced its financial results for the fiscal quarter ended September 29, 2018.
- 2The company's earnings announcement was made via a press release attached as Exhibit 99.1 to the 8-K filing.
- 3The 8-K filing serves as the official record for the dissemination of TMO's quarterly financial performance.
- 4Investors can find detailed financial data, including revenue and earnings, within the press release incorporated by reference.
- 5This filing provides insight into the company's operational and financial condition as of the end of Q3 2018.
- 6The information furnished via this 8-K is not considered 'filed' under Section 18 of the Exchange Act, limiting liability but still conveying key performance information.